Dear Molecular Imaging Community,
In recent weeks, I have been captivated and humbled by how our community has gathered to support one another. I hope this newsletter offers you support, tools and strategies as many of you are isolating at home. At Magnetic Insight, the team is working remotely while essential business operations continue at our headquarters. We have adapted to working offsite and found ourselves busier than ever supporting MPI grant submissions, data analysis and technical seminars!
We are particularly excited about sponsoring the online conference, Rising Stars in Magnetic Particle Imaging and Molecular Imaging, taking place on April 21st and April 22nd at 12 PM EST. Registration is now open.
This season’s newsletter offers short reviews on novel approaches to lung imaging, therapeutic delivery and inflammation with MPI. MPI has broken new ground in unchartered areas of research for therapeutic development at an accelerated pace. In fact, just in the first few months of 2020, we have experienced the largest surge in publications in the history of MPI. We selected a few notable publications below.
All of us from the Magnetic Insight team wish you a safe and healthy isolation with a special heartfelt gratitude to our molecular imaging family working tirelessly in the clinic.
Anna Christensen, PhD
President & CEO Magnetic Insight
In the light of major conference cancellations, the magnetic particle imaging community has decided to maintain our fast progress in molecular imaging and support the trainees that are hard at work producing ground-breaking data.
We are pleased to invite you to participate in the Magnetic Particle Imaging Rising Stars 2020 Molecular Imaging eSymposia, taking place on April 21st and 22nd at 12 PM EST.
Speakers & Presenters:
Caylin Colson, UC Berkeley:
Evidence that SPIO Chain Formation is Essential for Super-Resolution MP
Olivia Seh, Robarts Research Institute, The University of Western Ontario:
A comparison of MRI and MPI for the longitudinal detection and quantification of ferumoxytol-labelled mesenchymal stem cells in vivo
Yapei Zhang, Michigan State University:
Quantitative drug release monitoring in tumors of living subjects by magnetic particle imaging nanocomposite
The importance of early diagnostics and therapeutic development for Acute respiratory distress syndrome (ARDS) has risen sharply since the onset of the coronavirus epidemic in late 2019. Groundbreaking work on diagnostics and therapeutics for assessing and treating ARDS through direct delivery of therapeutics via inhalation is beginning to show promise. For these diagnostics and therapeutics, nanotechnology can now enable non-invasive assessment of lung function, mucociliary transport (MCT), and monitoring of nanotherapeutic delivery.